Extensive research has demonstrated that MTFP1 dysfunction can lead to mitochondrial fragmentation, enhanced oxidative stress, and cell death, all of which contribute to the onset and progression of metabolic diseases, cardiovascular disorders, and cancer, underscoring its potential as a therapeutic target for multi-system diseases. The gene discussed is MTFP1; the disease is cardiovascular disorder.